168 related articles for article (PubMed ID: 14559095)
1. Targeting metalloenzymes: a strategy that works.
White RJ; Margolis PS; Trias J; Yuan Z
Curr Opin Pharmacol; 2003 Oct; 3(5):502-7. PubMed ID: 14559095
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in metalloprotein inhibition.
Rouffet M; Cohen SM
Dalton Trans; 2011 Apr; 40(14):3445-54. PubMed ID: 21290034
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Selected Bacterial Metalloenzymes.
Žalubovskis R; Winum JY
Curr Med Chem; 2019; 26(15):2690-2714. PubMed ID: 29611472
[TBL] [Abstract][Full Text] [Related]
4. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
Proteau PJ
Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
[TBL] [Abstract][Full Text] [Related]
5. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
[TBL] [Abstract][Full Text] [Related]
6. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Deng L; Sundriyal S; Rubio V; Shi ZZ; Song Y
J Med Chem; 2009 Nov; 52(21):6539-42. PubMed ID: 19888756
[TBL] [Abstract][Full Text] [Related]
7. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.
Zhang J; Zhang L; Li X; Xu W
Curr Med Chem; 2012; 19(13):2038-50. PubMed ID: 22414079
[TBL] [Abstract][Full Text] [Related]
8. Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives.
Di Leo R; Cuffaro D; Rossello A; Nuti E
Molecules; 2023 May; 28(11):. PubMed ID: 37298854
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
Uh E; Jackson ER; San Jose G; Maddox M; Lee RE; Lee RE; Boshoff HI; Dowd CS
Bioorg Med Chem Lett; 2011 Dec; 21(23):6973-6. PubMed ID: 22024034
[TBL] [Abstract][Full Text] [Related]
10. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
[TBL] [Abstract][Full Text] [Related]
11. Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
Phaosiri C; Proteau PJ
Bioorg Med Chem Lett; 2004 Nov; 14(21):5309-12. PubMed ID: 15454217
[TBL] [Abstract][Full Text] [Related]
12. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of Fluoroalkyl Phosphonyl Analogues of 2- C-Methylerythritol Phosphate as Substrates and Inhibitors of IspD from Human Pathogens.
Bartee D; Wheadon MJ; Freel Meyers CL
J Org Chem; 2018 Sep; 83(17):9580-9591. PubMed ID: 29870251
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5-phosphate reductoisomerase complexes.
Yajima S; Hara K; Sanders JM; Yin F; Ohsawa K; Wiesner J; Jomaa H; Oldfield E
J Am Chem Soc; 2004 Sep; 126(35):10824-5. PubMed ID: 15339150
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of lysine biosynthesis as antibacterial agents.
Hutton CA; Southwood TJ; Turner JJ
Mini Rev Med Chem; 2003 Mar; 3(2):115-27. PubMed ID: 12570844
[TBL] [Abstract][Full Text] [Related]
16. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
Brücher K; Illarionov B; Held J; Tschan S; Kunfermann A; Pein MK; Bacher A; Gräwert T; Maes L; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2012 Jul; 55(14):6566-75. PubMed ID: 22731758
[TBL] [Abstract][Full Text] [Related]
17. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues.
Ortmann R; Wiesner J; Silber K; Klebe G; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Sep; 340(9):483-90. PubMed ID: 17806130
[TBL] [Abstract][Full Text] [Related]
18. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors.
Jackson ER; Dowd CS
Curr Top Med Chem; 2012; 12(7):706-28. PubMed ID: 22283814
[TBL] [Abstract][Full Text] [Related]
20. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
Yuan Z; White RJ
Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
